Tag: Cancer: Colon
Triple Treatment Combo Beneficial in BRAF-Mutant CRC
Irinotecan, cetuximab, and vemurafenib improve progression-free survival in BRAFV600E-mutated colorectal cancer
Early-Onset CRC Incidence Examined by Histologic Subtype
Adenocarcinomas increasing in most early-onset subgroups; carcinoid tumors increasing more steeply in all age groups
Hot Spots ID’d for Higher CRC Mortality in Younger Women
Nearly one in 16 U.S. counties are hot spots, with the majority in the South
Pembrolizumab Slows MSI-H-dMMR Metastatic CRC
Pembrolizumab superior to chemo for progression-free survival among patients who had not previously received treatment
Colon Cancer Diagnosed Earlier Under Medicaid Expansion
Medicaid expansion also may result in improved access to treatment, including palliative care
Laparoscopic Resection May Be An Option for CRC Liver Metastases
For resectable colorectal liver metastases, five-year survival rates similar with laparoscopic, open surgery
Surgeon Skill Level Tied to Colon Cancer Surgery Survival
Highly skilled surgeons may boost colon cancer survival by 70 percent
USPSTF Issues Draft Recommendation for CRC Screening
Benefit substantial for adults aged 50 to 75 years; benefit moderate for adults aged 45 to 49 years
Review IDs Dietary Factors Linked to Lower CRC Incidence
Incidence up with frequent alcohol or meat consumption; no evidence of protective effect found for tea, coffee
High-Risk Patients Not Aware of Needed Colonoscopy Intervals
Findings among patients with biopsy-confirmed advanced colorectal polyps
